The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
Open accessThe DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
Abstract
Insulin resistance arises when the nutrient storage pathways evolved to maximize efficient energy utilization are exposed to chronic energy surplus. Ectopic lipid accumulation in liver and skeletal muscle triggers pathways that impair insulin signaling, leading to reduced muscle glucose uptake and decreased hepatic glycogen synthesis. Muscle insulin resistance, due to ectopic lipid, precedes liver insulin resistance and diverts ingested glucose to the liver, resulting in increased hepatic de novo lipogenesis and hyperlipidemia. Subsequent macrophage infiltration into white adipose tissue (WAT) leads to increased lipolysis, which further increases hepatic triglyceride synthesis and hyperlipidemia due to increased fatty acid esterification. Macrophage-induced WAT lipolysis also stimulates hepatic gluconeogenesis, promoting fasting and postprandial hyperglycemia through increased fatty acid delivery to the liver, which results in increased hepatic acetyl-CoA content, a potent activator of pyruvate carboxylase, and increased glycerol conversion to glucose. These substrate-regulated processes are mostly independent of insulin signaling in the liver but are dependent on insulin signaling in WAT, which becomes defective with inflammation. Therapies that decrease ectopic lipid storage and diminish macrophage-induced WAT lipolysis will reverse the root causes of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Supporting this perspective, monosaccharides have been shown to activate ChREBP and other key lipogenic transcription factors—including SREBP1c, LXR, and PPARγ—via insulin-independent mechanisms [34,70,83,86,99].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [99]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In both animal models and human patients, obesity‐induced hyperlipidaemia and lipotoxicity‐induced inflammation is thought to be one of the drivers for SO.[ 63 ]”
From Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review (2022) · cites this paper as [63]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In lipid infusion experiments, DAG content in the muscle increases, and consequently PKCθ is activated, resulting in limited phosphorylation of IRS-1 and glucose uptake through GLUT4 [9].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [9]
In the citing paper
“Insulin resistance is the core mechanism of sarcopenic obesity and is also associated with variable cardiometabolic diseases such as cardiovascular disease, type 2 diabetes mellitus, and non-alcoholic fatty liver disease.”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“Activated adipose tissue macrophages (ATMs) are recruited via chemokine signaling (96, 97) and release cytokines that promote lipolysis.”
BackgroundThe metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760 · cited 1×
“Activated adipose tissue macrophages (ATMs) are recruited via chemokine signaling (96, 97) and release cytokines that promote lipolysis.”
BackgroundLippa, N. C., & Sanderson, S. C. (2013) · Human Heredity · doi:10.1159/000353712 · Cited by 6,078
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093 · cited 2×
“Over a half century ago, Randle and colleagues concluded that muscle insulin resistance associated with obesity could be attributed to increased fatty acid oxidation that limits insulin-stimulated glucose utilization (43).”
BackgroundGenetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416 · cited 1×
“A common single nucleotide polymorphism (rs738409, I48M) in the lipid droplet protein patatin-like phospholipase domaincontaining protein 3 (PNPLA3, also called adiponutrin) has been associated with increased hepatic steatosis but not insulin resistance (74).”
BackgroundKim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833 · cited 1×
“Insulin activates the insulin receptor tyrosine kinase (IRTK), with subsequent activation of kinases including 3-phosphoinositide-dependent kinase-1 (PDK1) and mTORC2 (6), which converge on Akt phosphorylation (6–8).”
BackgroundAlessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,826
Research works printed but not linked: 3
- 10.1210/jcem.87.8.8761 · doi:10.1210/jcem.87.8.8761 · Paper page
- Kersten, 2014, Physiological regulation of lipoprotein lipase, Biochim Biophys Acta, 1841, 919, 10.1016/j.bbalip.2014.03.013 · DOI · Paper page
- 10.1172/JCI10294 · DOI · Paper page
Cited by
Items 701–800 of 998
Estimating Drug Efficacy with a Diet-Induced NASH Model in Chimeric Mice with Humanized Livers
Kisoh, K., Sugahara, G., Ogawa, Y., Furukawa, S., Ishida, Y., Okanoue, T., Kohara, M., & Tateno, C. (2021) · Biomedicines · doi:10.3390/biomedicines9111647 · Cited by 15
Grundy, S. M. (2020) · Endocrinology · doi:10.1007/978-3-030-36694-0_3 · Cited by 17
Xu, P., Wang, M., Sharma, N., Comeau, M. E., Wabitsch, M., Langefeld, C. D., Civelek, M., Zhang, B., & Das, S. K. (2023) · Cell Systems · doi:10.1016/j.cels.2022.12.005 · Cited by 11
Lailerd, M., Linn, T. W., Lailerd, N., Amornlerdpison, D., & Imsumran, A. (2023) · Applied Sciences · doi:10.3390/app13116454 · Cited by 14
Li, L., Zhang, T., Yang, L., Zhang, L., Wang, L., Liu, B., & Liu, K. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.07.038 · Cited by 11
Shi, Y., Shu, Z.-J., Wang, H., Barnes, J. L., Yeh, C., Ghosh, P., Katz, M. S., & Kamat, A. (2017) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00372.2017 · Cited by 14
“Although disordered hepatic glucose and lipid metabolism in these age-related diseases is strongly associated with reduced sensitivity of liver to the actions of insulin (39), altered hepatic responsiveness to counterregulatory factors such as catecholamines might also play a role in the development of liver dysfuncti…”
Neuregulin 1 treatment improves glucose tolerance in diabetic db/db mice, but not in healthy mice
Ennequin, G., Caillaud, K., Chavanelle, V., Teixeira, A., Etienne, M., Li, X., Boisseau, N., & Sirvent, P. (2018) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2018.1534243 · Cited by 11
New molecular biomarkers in precise diagnosis and therapy of Type 2 diabetes
Mandal, Š. (2019) · Health and Technology · doi:10.1007/s12553-019-00385-6 · Cited by 16
Edmunds, L. R., Huckestein, B. R., Kahn, M., Zhang, D., Chu, Y., Zhang, Y., Wendell, S. G., Shulman, G. I., & Jurczak, M. J. (2019) · Physiological Reports · doi:10.14814/phy2.14281 · Cited by 12
“Hepatic steatosis is associated with insulin resistance (Samuel & Shulman, 2016).”
BackgroundResultSelf-citationNwadozi, E., Rudnicki, M., Ciantis, M. D., Milkovich, S., Pulbere, A., Roudier, E. A., Birot, O., Gustafsson, T. P., Ellis, C. G., & Haas, T. L. (2020) · Acta Physiologica · doi:10.1111/apha.13449 · Cited by 13
Leptin, adiponectin, lipodystrophic and severe insulin resistance syndromes
Vatier, C., Jéru, I., Fellahi, S., Capeau, J., Bastard, J., & Vigouroux, C. (2020) · Annales de biologie clinique · doi:10.1684/abc.2020.1551 · Cited by 13
Lee, D., Shin, Y., Roh, J., Ahn, J., Jeong, S., Shin, S. C., & Yoon, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124256 · Cited by 12
“The intake of HFD by C57BL/6J mice is a robust model of debilitated glucose tolerance and initial T2D [30].”
BackgroundInfluentialRetractedScariot, P. P. M., Manchado-Gobatto, F. D. B., van Ginkel, P. R., Prolla, T. A., & Gobatto, C. A. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.07.018 · Cited by 15
Rezazadeh, H., Sharifi, M. R., Sharifi, M., & Soltani, N. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174418 · Cited by 12
de Azua, M. J. R., Cruz‐Carrión, Á., Muguerza, B., Arola‐Arnal, A., & Suárez, M. (2021) · Nutrients · doi:10.3390/nu13103643 · Cited by 11
“A higher concentration of circulating NEFAs is strongly associated with faulty insulin signaling [51].”
BackgroundDunlop, K., Sarr, O., Stachura, N., Zhao, L., Nygard, K. L., Thompson, J. A., Hadway, J. A., Richardson, B. S., Bureau, Y., Borradaile, N. M., et al. (2021) · Nutrients · doi:10.3390/nu13124315 · Cited by 15
“Prior to whole-body insulin resistance being detected, multiple organs develop insulin resistance, with muscle developing insulin resistance prior to other organs, such as the liver and white adipose tissue, with a cascade effect then occurring that is finally displayed as whole-body insulin resistance and glucose int…”
BackgroundLiu, L., Sun, K., Luo, Y., Wang, B., Yang, Y., Chen, L., Zheng, S., Wu, T., & Xiao, P. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121470 · Cited by 11
Pathogenesis of Type 2 Diabetes Mellitus
DeFronzo, R. A. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_8-1 · Cited by 13
Nakamoto, A., Ohashi, N., Sugawara, L., Morino, K., Ida, S., Perry, R. J., Sakuma, I., Yanagimachi, T., Fujita, Y., Ugi, S., et al. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00263.2022 · Cited by 11
Self-citationLipid metabolism in the immune niche of tumor-prone liver microenvironment
Chen, J., Chan, T. T.-H., & Zhou, J. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiad081 · Cited by 13
Hepatic sialic acid synthesis modulates glucose homeostasis in both liver and skeletal muscle
Peng, J., Yu, L., Huang, L., Paschoal, V. A., Chu, H., de Souza, C. O., Varre, J. V., Oh, D. Y., Kohler, J. J., Xiao, X., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101812 · Cited by 12
“Insulin action via hepatic IR decreases gluconeogenesis and glycogenolysis and it increases glycogenesis, and glucagon activation of hepatic GCGR promotes glycogenolysis and gluconeogenesis and attenuates glycogenesis [14,15].”
BackgroundTargeting phospholipid remodeling pathway improves insulin resistance in diabetic mouse models
Tian, Y., Lu, W., Shi, R., McGuffee, R. M., Lee, R. G., Ford, D. A., & Wang, B. (2023) · The FASEB Journal · doi:10.1096/fj.202301122rr · Cited by 13
Testosterone and Glucose Homeostasis in Adult Males: Current Insights and Future Prospects
Milionis, C., Koukkou, E. G., Venaki, E., & Ilias, Ι. (2024) · Discovery Medicine · doi:10.24976/discov.med.202436184.81 · Cited by 12
Langlois, A., Cherfan, J., Meugnier, E., Rida, A., Arous, C., Péronet, C., Hamdard, H., Zarrouki, B., Wehrle‐Haller, B., Pinget, M., et al. (2025) · Acta Physiologica · doi:10.1111/apha.14267 · Cited by 16
Chen, F., Niu, Y., Wu, R., Jiang, H., Zhu, J., Wang, C., Xia, X., & Jin, Y. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1516591 · Cited by 14
Biological Pathways Leading From ANGPTL8 to Diabetes Mellitus–A Co-expression Network Based Analysis
Siddiqa, A., Cirillo, E., Tareen, S. H. K., Ali, A., Kutmon, M., Eijssen, L., Ahmad, J., Evelo, C. T., & Coort, S. L. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01841 · Cited by 11
“The underlying pathogenic mechanisms are well studied and encompass deregulated glucose and lipid homeostasis involving inter-organ crosstalk of substrates and hormones (Samuel and Shulman, 2016).”
Zhou, J., Dong, X., Liu, Y., Jia, Y., Wang, Y., Zhou, J., Jiang, Z., & Chen, K. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej19-0455 · Cited by 11
Bagheri, M. H., Jazi, A. A., Banitalebi, E., Kazeminasab, F., & Nasr‐Esfahani, M. H. (2020) · Science & Sports · doi:10.1016/j.scispo.2020.01.006 · Cited by 12
Taltavull, N., Miralles‐Pérez, B., Nogués, M. R., Ramos‐Romero, S., Méndez, L., Medina, I., Torres, J. L., & Romeu, M. (2020) · Marine Drugs · doi:10.3390/md18060318 · Cited by 11
“This accumulation of hepatic DAG species in HFHS group could lead to insulin resistance and the development of hepatic steatosis [2] via protein kinase C ε (PKCε) activation and the resulting inhibition of the insulin receptor, as previously described [5,38].”
BackgroundPark, J. M., Josan, S., Hurd, R. E., Graham, J. L., Havel, P. J., Bendahan, D., Mayer, D., Chung, Y., Spielman, D. M., & Jue, T. (2021) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-021-02613-3 · Cited by 10
Jiang, Q., Chen, Y., Jing-Jie, M. A., Wang, Y. Y., Ping, L. I., Wen, X., & Yang, J. (2022) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(21)60115-2 · Cited by 12
Markovič, R., Grubelnik, V., Vošner, H. B., Kokol, P., Završnik, M., Janša, K., Zupet, M., Završnik, J., & Marhl, M. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020280 · Cited by 19
“The mechanisms of the relationship between insulin resistance and dyslipidemia are complex and were recently reviewed in [32,33].”
BackgroundYou, J., Zhao, M., Chen, S., Jiang, L., Gao, S., Yin, H., & Zhao, L. (2022) · Bioresources and Bioprocessing · doi:10.1186/s40643-022-00579-3 · Cited by 13
“COS sustained glucose homeostasis and regulated the metabolism of glucose IR in the skeletal muscles and liver is considered pathogenic of T2DM (Samuel and Shulman 2016).”
BackgroundEffects of Anterior Pituitary Adenomas’ Hormones on Glucose Metabolism and Its Clinical Implications
Li, M., Zhang, J., Yang, G., Zhang, J., Han, M., Zhang, Y., & Liu, Y. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s397445 · Cited by 12
“(IRS-PI3K-AKT) in rats treated with GCs leads to compensatory hyperinsulinemia, which in turn increases insulin resistance in the liver through a vicious pre-cycle.(66) GCs increase the blood glucose level by its effects on the liver as described above.”
BackgroundThe association between skipping breakfast and chronic kidney disease
Gahm, C., & Park, S. (2023) · International Urology and Nephrology · doi:10.1007/s11255-023-03590-5 · Cited by 10
“Insulin resistance is associated with skipping breakfast [35, 36].”
Backgroundde la Fuente-Muñoz, M., de la Fuente‐Fernández, M., Roman, M. N., Amor, S., de la Cruz, M. D. C. I., García‐Laínez, G., Llopis, S., Martorell, P., Verdú, D., Serna, E., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108521 · Cited by 15
“Although the physiopathological mechanisms involved in the development of insulin resistance vary among tissues, it is well known that lipotoxicity, a phenomenon caused by an excessive accumulation of lipid intermediates, such as triglycerides, diacylglycerols (DAGs), or ceramides, is a common feature among all of the…”
BackgroundWang, Q., Li, H., Lu, H., Wang, S., Li, Y., Zhang, Z., Han, J., Yang, Z., Yang, Y., & Hong, Y. (2023) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2023.112043 · Cited by 10
Shi, L., Wang, J., He, C., Huang, Y. Q., Fu, W., Zhang, H., An, Y., Wang, M., Shan, Z., Li, H., et al. (2023) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-023-04140-3 · Cited by 11
“Muscle IR is directly associated with an increase in hepatic de novo-lipogenesis and subsequent increases in circulating triglycerides, very-low-density lipoprotein cholesterol, as well as a decrease in high-density lipoprotein cholesterol [64].”
BackgroundWei, R., Chen, S., Huang, X., Zhai, Z., Wang, Q., Sun, J., Mo, J., Huang, J., Xu, Y., & Lu, W. (2024) · International Wound Journal · doi:10.1111/iwj.14874 · Cited by 11
“10 Given this, an active assessment of the IR situation is helpful for the early identification of high-risk patients with T2DM and its chronic complications.”
BackgroundPeck, B. D., Huot, J. R., Renzi, T., Arthur, S. T., Turner, M. J., & Marino, J. S. (2017) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00521.2016 · Cited by 12
Assessment of mouse liver [1-13C]pyruvate metabolism by dynamic hyperpolarized MRS
Høyer, K. F., Laustsen, C., Ringgaard, S., Qi, H., Mariager, C. Ø., Nielsen, T. S., Sundekilde, U. K., Treebak, J. T., Jessen, N., & Stødkilde‐Jørgensen, H. (2019) · Journal of Endocrinology · doi:10.1530/joe-19-0159 · Cited by 10
“These findings could be explained by phosphoenolpyruvate carboxykinase inhibition and reduced pyruvate carboxylase activity by insulin (Samuel & Shulman 2016).”
BackgroundPhospholipase D as a Potential Modulator of Metabolic Syndrome: Impact of Functional Foods
Auclair, N., Sané, A. T., DELVIN, E. E., Spahis, S., & Levy, E. H. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8081 · Cited by 11
“In PLD1 and PLD2 knockout mice, blood samples showed a significant elevation of free fatty acid concentrations (228), which generally promote IR (211).”
Mechanisms of protective effects of astaxanthin in nonalcoholic fatty liver disease
Gao, L.-J., Zhu, Y., & Xu, L. (2021) · Hepatoma Research · doi:10.20517/2394-5079.2020.150 · Cited by 11
Wu, Y. S., Lin, Y., Yang, W., Wang, S., & Chen, Y. (2021) · Journal of Food and Drug Analysis · doi:10.38212/2224-6614.3351 · Cited by 16
“Besides, previous studies reported that the decreased hepatic lipid deposition against an excessive energy intake could highly correlate to the balance of triglyceride (TG) synthesis and energy expenditure (fatty-acid b oxidation), which are both modulated by up-streaming insulin signal, thus emphasizing the crucial r…”
BackgroundInfluentialAsociación entre obesidad sarcopénica con resistencia a la insulina y síndrome metabólico
Pérez‐Cruz, E., Castro-Martínez, D., & Guzmán, O. P. G. (2021) · Medicina Clínica · doi:10.1016/j.medcli.2021.07.023 · Cited by 13
Obesity: Molecular Mechanisms, Epidemiology, Complications and Pharmacotherapy
Jaberi, S. A., Cohen, A., Saeed, Z., Ojha, S. K., Singh, J., & Adeghate, E. A. (2021) · Advances in biochemistry in health and disease · doi:10.1007/978-3-030-84763-0_13 · Cited by 10
Ortiz-Huidobro, R. I., Larqué, C., Velasco, M., Chávez‐Maldonado, J. P., Sabido, J. R., Sánchez-Zamora, Y. I., & Hiriart, M. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00965-6 · Cited by 12
“It is a central component of metabolic syndrome and a common feature in the history of patients who develop type 2 diabetes mellitus (T2DM) [2, 5, 18].”
BackgroundInfluentialJamalat, Y., Gamallat, Y., Gislaine, P. S. J., Meyiah, A., Shopit, A., Li, H., Ahmed, B., Chu, P., Wang, H., Li, X., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.10.122 · Cited by 10
Wattanavanitchakorn, S., Ansari, I. H., Azzouny, M. E., Longacre, M. J., Stoker, S. W., MacDonald, M. J., & Jitrapakdee, S. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.108124 · Cited by 9
Xu, L., Jia, J., Miao, S., Gong, L., Wang, J., He, S., & Zhang, Y. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121696 · Cited by 9
Changes in Isoleucine, Sarcosine, and Dimethylglycine During OGTT as Risk Factors for Diabetes
Liu, Y., Liu, X., He, Q., Huang, X., Ren, Y., & Zuo-liang, D. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae018 · Cited by 9
Calixto-Tlacomulco, S., Luna-Reyes, I., Delgado‐Coello, B., Gutiérrez‐Vidal, R., Reyes‐Grajeda, J. P., & Mas‐Oliva, J. (2024) · Archives of Medical Research · doi:10.1016/j.arcmed.2023.102937 · Cited by 9
Yang, C., You, N., Chen, Y., & Zhang, J. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09597-2 · Cited by 11
Dimitriadis, K. S., Iliakis, P., Vakka, A., Pyrpyris, N., Pitsillidi, A., Tsioufis, P., Fragkoulis, C., Hering, D., Weil, J., Κόλλιας, Α., et al. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000000850 · Cited by 11
Wu, B., Yu, W., Zhang, G., Jiang, H., & Wu, N. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02872-9 · Cited by 11
“Second, this index may be related to the metabolism of glycosylation end products and platelet reactivity, thereby affecting endothelium-dependent vasodilation [57].”
Aguree, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178304 · Cited by 15
“…genetic and pharmacological, has been shown to attenuate adipocyte hypertrophy induced by a high-fat diet and improve insulin signaling in adipose tissue, the liver, and skeletal muscle, which is often associated with increased Akt/PKB phosphorylation and improved glucose uptake [17,47,96,98,99].”
Dinu, A., Confederat, L. G., Dragostin, I., Morariu, I. D., Tutunaru, D., & Dragostin, O.-M. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47090709 · Cited by 9
“Therefore, insulin resistance can be treated on the one hand by lifestyle changes, with physical activity and diet being important in this case; on the other hand, drug treatment can improve insulin response, thus reducing insulin demand [45].”
SNAITH, J. R., Olsen, N., Evans, J., Kowalski, G. M., Bruce, C. R., Samocha‐Bonet, D., Breit, S. N., Holmes-Walker, D. J., & Greenfield, J. R. (2025) · Nature Communications · doi:10.1038/s41467-025-65951-1 · Cited by 10
“Further, impaired suppression of lipolysis may increase gluconeogenic substrate fl ux (such as fatty acids or glycerol) from peripheral adipose tissue to the liver which then interfere with insulin sensitivity at the hepatic site 44 .”
How Adipocytes Orchestrate Inflammation Within Adipose Tissue?
Higos, R., Renzi, G., Taillandier, P., Merabtene, F., Rouault, C., Abatan, J. B., Lambert, M., Dugail, I., Clément, K., Marcelin, G., et al. (2025) · Biomolecules · doi:10.3390/biom16010059 · Cited by 13
“This so-called “meta-inflammatory” state underpins adipocyte dysfunction and local insulin resistance, propagates systemic insulin resistance, and accelerates the development of type 2 diabetes mellitus (T2DM) [3,12].”
Li, X., Benegiamo, G., Vijayakumar, A., SRODA, N., Kimura, M., Huss, R. S., WENG, S., Murakami, E., Kirby, B. J., von Alvensleben, G., et al. (2026) · Nature Medicine · doi:10.1038/s41591-025-04169-6 · Cited by 10
“Dyslipidemia commonly accompanies insulin resistance and type 2 diabetes, and ectopic lipid accumulation in liver and skeletal muscle contributes causally to the development of insulin resistance 54 .”
Insulin resistance: mechanisms and therapeutic interventions
Yu, L., Qian, J., Li, X., Tian, M., Bai, X., Yang, J., Deng, R., Lu, C., He, X., Lü, A., et al. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00408-5 · Cited by 14
Akinnuga, A. M., Siboto, A., Khumalo, B., Sibiya, N. H., Ngubane, P. S., & Khathi, A. (2020) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2020/2475301 · Cited by 10
“In the prediabetic state, as glucose delivery to the liver increases, de novo lipogenesis and hepatic lipid accumulation increase under the influence of transcription factors such as SREBP1c [6, 14, 37, 40].”
BackgroundResultInfluentialKostić, M., Korićanac, G., Tepavčević, S., Stanišić, J., Romić, S., Ćulafić, T., Ivković, T., & Stojiljković, M. (2021) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2021.1886118 · Cited by 10
“…and processed food, triggers hyperlipidaemia, insulin resistance, inflammation, oxidative stress, obesity and chronic diseases such as hypertension and Type 2 diabetes mellitus, all risk factors for cardiac dysfunction (Kelishadi et al. 2014, Francisqueti et al. 2016, Samuel and Shulman 2016).”
BackgroundThe Role of LTB4 in Obesity-Induced Insulin Resistance Development: An Overview
Callegari, I. O. M., & Oliveira, A. G. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.848006 · Cited by 11
“Increased levels of free fatty acids are certainly one of the mechanisms involved in the proinflammatory state that link obesity to insulin resistance (20).”
BackgroundShi, H., Prough, R. A., McClain, C. J., & Song, M. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109189 · Cited by 11
MAD2-Dependent Insulin Receptor Endocytosis Regulates Metabolic Homeostasis
Park, J., Hall, C., Hubbard, B. T., LaMoia, T. E., Gaspar, R. C., Nasiri, A. R., Li, F., Zhang, H., Kim, J., Haeusler, R. A., et al. (2023) · Diabetes · doi:10.2337/db23-0314 · Cited by 10
Self-citationBai, Y., Morita, K., Kokaji, T., Hatano, A., Ohno, S., Egami, R., Pan, Y., Li, D., Yugi, K., Uematsu, S., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109121 · Cited by 8
Xie, X., Liu, Y., Yang, Q., Ma, X., Lu, Y., Hu, Y., Zhang, G., Ke, L., Tong, Z., Liu, Y., et al. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.03.014 · Cited by 9
Cytokines in Diabetes and Diabetic Complications
Rivero-González, A., Izquierdo, E. M., Delgado, C. M., Rodríguez-Muñoz, A., & Navarro‐González, J. F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804214-4.00006-3 · Cited by 11
Hansen, D., Verboven, K., van Dijk, J., Zorenc, A. H. G., Minten, L., Smeets, K., Verdijk, L. B., & van Loon, L. J. C. (2018) · European Journal of Sport Science · doi:10.1080/17461391.2018.1483428 · Cited by 9
Belmonte, F. R., Dedousis, N. L., SIPULA, I. J., Desai, N., Singhi, A. D., Chu, Y., Zhang, Y., Bannwarth, S., Paquis‐Flucklinger, V., Harrington, L. A., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0203101 · Cited by 10
“Similarly, the absence of changes in fasting blood glucose concentrations and glucose tolerance despite increased hepatic steatosis in WD-fed PIF1 KO females was surprising given the strong, positive association between liver fat, hyperglycemia and hepatic insulin resistance [32-34].”
BackgroundZhao, M., Harris, B. N., Nguyen, C. T. Y., & Saltzman, W. (2019) · Hormones and Behavior · doi:10.1016/j.yhbeh.2019.05.005 · Cited by 12
Akinnuga, A. M., Siboto, A., Khumalo, B., Sibiya, N. H., Ngubane, P. S., & Khathi, A. (2019) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2019.1680697 · Cited by 12
“Consequently, the muscle protein kinase C (PKCh) is activated and limited phosphorylation of insulin receptor substrate-1 (IRS-1) occurred (Samuel and Shulman 2016).”
BackgroundInfluentialFrança, L. M., dos Santos, P. C., Barroso, W. A., Gondim, R. S. D., Coêlho, C. F. F., Flister, K. F. T., & Paes, A. M. D. A. (2020) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174420000598 · Cited by 12
Jia, H., Han, L., Zhang, Y., & Wang, T. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/1057648 · Cited by 10
Coordinated regulation of miR-27 by insulin/CREB/Hippo contributes to insulin resistance
Chen, Y., Chueh, L.-Y., Lee, S.-Y., Ma, P.-F., Chen, P.-C., & Hsu, S. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.109930 · Cited by 10
Yang, X., Chen, Q., Ouyang, Q., Rong, P., Feng, W., Quan, C., Li, M., Jiang, Q. Y., Liang, H., Zhao, T., et al. (2021) · Diabetes · doi:10.2337/db21-0039 · Cited by 9
Lipotoxicity in a Vicious Cycle of Pancreatic Beta Cell Exhaustion
Grubelnik, V., Zmazek, J., Završnik, M., & Marhl, M. (2022) · Biomedicines · doi:10.3390/biomedicines10071627 · Cited by 12
“The influence of lipids on glucose metabolism, particularly the role of ectopic lipid accumulation, requires a systemic approach in a complex circuit of the endocrine pancreas and its hormone-targeted tissues, especially the liver and muscle [3,4].”
BackgroundLiu, C., Feng, H., Zhang, L., Guo, Y., Ma, J., & Yang, L. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11780 · Cited by 11
“The former is a common feature of GDM, where alleviating insulin resistance using pioglitazone clinically has become an effective approach for treating this condition (6,7).”
Subramaniam, S., Ong, K. C., Sabaratnam, V., Chua, K. H., & Kuppusamy, U. R. (2023) · International journal of medicinal mushrooms · doi:10.1615/intjmedmushrooms.2023047595 · Cited by 10
Zabielski, P., Imierska, M., Roszczyc-Owsiejczuk, K., Kuźmicki, M., Rogalski, P., Daniluk, J., & Błachnio-Zabielska, A. U. (2024) · Nutrients · doi:10.3390/nu16071003 · Cited by 9
“Similar decreases in the liver glycogen content in insulin-resistant humans and animals have also been observed by other researchers [46,47].”
BackgroundResultZhang, Z., Luan, C., Wang, C., Li, T., Wu, Y., Huang, X., Jin, B., Zhang, E., Gong, Q., Zhou, X., et al. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.134504 · Cited by 8
Sardar, M. B., Raza, M., Fayyaz, A., Nadir, M. A., Nadeem, Z. A., & Babar, M. (2024) · Cardiovascular Toxicology · doi:10.1007/s12012-024-09913-x · Cited by 10
“Oxidation of sources of energy other than glucose such as triacylglycerols (TAGs) [35] then plays a crucial role in fulfilling the energy requirements of the body.”
Elfaki, I., Mir, R., Elnageeb, M. E., Hamadi, A., Alharbi, Z. M., Bedaiwi, R. I., Javid, J., Alrasheed, T., Alatawi, D., Alrohaf, B. M., et al. (2025) · Medicina · doi:10.3390/medicina61010083 · Cited by 11
“The reduced density of mitochondria may be caused by the decreased expression of the lipoprotein lipase (LpL) gene in skeletal muscle [11].”
InfluentialDu, J., Shen, M., Chen, J., Yan, H., Xu, Z., Yang, X., Yang, B., Luo, P., Ding, K., Hu, Y., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1510080 · Cited by 11
Tang, H., Wang, K., Zheng, K., Wen, Z., Yang, Y., Mo, S., Nie, X., Lan, C., Liu, Q., & Wang, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-03583-7 · Cited by 8
“Additionally, the imbalance metabolism of glucose and lipids may synergistically exacerbate the platelet function 32 .”
Pathogenesis and Clinical Management of Metabolic Dysfunction-Associated Steatotic Liver Disease
Lucaciu, R. L., Coste, S. C., Hangan, A. C., Iancu, M., Orasan, O. H., Cozma, A., Bogdan, S. G., & Procopciuc, L. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125717 · Cited by 14
“The insulin resistance is involved in increasing gluconeogenesis and “de novo” lipogenesis [34].”
Etiology of Delayed Lactogenesis in Obesity
Gomez‐Casado, G., García, N. S., González‐Mesa, E., & Ortega‐Gómez, A. (2025) · Biomedicines · doi:10.3390/biomedicines13081848 · Cited by 8
“Hepatic insulin resistance in obesity leads to elevated gluconeogenesis and dysregulated insulin growth factor/growth hormone (IGF/GH) signaling [54].”
Kosugi, S., Yamaguchi, S., Nishioka, K., Nagahisa, T., Watanabe, Y., Kojima, D., Kaneko, K., Mitsuno, R., Nakamichi, R., Kawano, Y., et al. (2025) · Aging Cell · doi:10.1111/acel.70222 · Cited by 9
Marková, I., Hüttl, M., Šťastný, J., Zapletalová, I., Kačer, P., Hönig, V., Kačerová, T., & Malínská, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-22745-1 · Cited by 10
Rewiring lipid Metabolism: The central role of CPT1 in metabolic dysfunction
Ni, D., Liu, Y., Lin, X., Luo, M., Deng, C., Li, J., Liang, P., Liu, Z., & Jiang, B. (2025) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2025.11.002 · Cited by 14
Metabolite and nutrient regulation of macrophages in obesity and metabolic disease
Sprenkle, N. T., & Mills, E. L. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-026-01292-4 · Cited by 15
Gale, J. T., Martin, H., Haszard, J. J., & Peddie, M. C. (2026) · Obesity Reviews · doi:10.1111/obr.70152 · Cited by 11
Relevance of lipid droplets in metabolic dysfunction-associated steatotic liver disease
Weiskirchen, R., & Lonardo, A. (2026) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2026.2671694 · Cited by 9
“…conditions, lipolytic activity becomes disconnected from nutritional and hormonal signals eventually resulting in inappropriate fatty acid mobilization, even during the post-prandial period, when hepatocytes are already receiving a high influx from the gut and adipose tissue [103].”
Pratiwi, R. Y., Elya, B., Setiawan, H., & Solawati, A. (2021) · Pharmacognosy Journal · doi:10.5530/pj.2021.13.199 · Cited by 8
Shevchenko, E. A., Потемина, Т. Е., & Uspensky, A. N. (2021) · Bulletin of the Medical Institute REAVIZ (REHABILITATION DOCTOR AND HEALTH) · doi:10.20340/vmi-rvz.2022.1.clin.3 · Cited by 10
Garg, P. K., Biggs, M. L., Kizer, J. R., Shah, S. J., Psaty, B. M., Carnethon, M. R., Gottdiener, J. S., Siscovick, D. S., & Mukamal, K. J. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01547-z · Cited by 9
“Given that skeletal muscle and adipose tissue IR are important determinants of increased free fatty acid levels and ectopic fat deposition, it was important to assess their potential effects separately from those of hepatic IR [28].”
BackgroundZhang, J., Hu, M., Jia, Y., Zhao, S., Lv, P., Fan, M., Shi, Y., & Jin, W. (2022) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2022.08.019 · Cited by 8
“On the other hand, increased TG level can stimulate hepatic gluconeogenesis, promoting fasting and postprandial hyperglycemia through increased fatty acid delivery to the liver, which will increase the burden of islet B cell and results in IR over time [57].”
BackgroundVorotnikov, A. V., Popov, D. V., & Makhnovskii, P. A. (2022) · Biochemistry (Moscow) · doi:10.1134/s0006297922090139 · Cited by 9
“As a result, levels of free fatty acids and triglyceride-rich lipoproteins in the blood plasma increase, leading to accumulation of ectopic fat in visceral tissues including skeletal muscle [21, 25, 26].”
Backgroundde Oliveira, D. S., Borges, I. B. P., Marie, S. K. N., Lerário, A. M., Oba‐Shinjo, S. M., & Shinjo, S. K. (2023) · Archives of Rheumatology · doi:10.46497/archrheumatol.2023.9257 · Cited by 12
Metadata
- Authors
- Samuel, V. T., & Shulman, G. I.
- Affiliations
- Veterans Health Administration (US)
- Howard Hughes Medical Institute (US)
- Venue
- Journal of Clinical Investigation
- Published
- 2016-01-04
- Volume
- 126
- Issue
- 1
- Pages
- 12-22
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC4701542
- OpenAlex
- W2230222215
- Cited by
- 1,484
- References
- 131
- Citations by year
- 2026: 192 · 2025: 162 · 2024: 152 · 2023: 150 · 2022: 150 · 2021: 143 · 2020: 134 · 2019: 136 · 2018: 114 · 2017: 99 · 2016: 51
- FWCI
- 18.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01 BX000901)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-49230, R01DK049230, DK40936, DK 45735, R01DK040936, U24DK059635, R24DK085638, DK059635, DK-085638, P30DK045735)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- insulin resistance, type 2 diabetes, ectopic fat deposition, hepatic insulin signaling, skeletal muscle glucose uptake, hepatic gluconeogenesis, hepatic de novo lipogenesis, adipose tissue lipolysis, hepatic triglyceride synthesis, fatty acid esterification, hyperlipidemia, hyperglycemia, pyruvate carboxylase, acetyl-CoA, substrate flux, inflammation, energy surplus
- MeSH terms
- Adipose Tissue, Animals, Glucose, Humans, Insulin Resistance, Liver, Triglycerides, Signal Transduction, Muscle, Skeletal, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.